1st Quarter - Amendment — ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH (2024)

Firm

ALLIANCE FOR AGING RESEARCH

Client

ALLIANCE FOR AGING RESEARCH

Income

—

Expenses

$110,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report	Apr 20, 2024	—	Replaced
1st Quarter - Amendment (this page)	Mar 6, 2025	$110,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform

Lobbyist	Covered position, as disclosed
ADINA ROSE LASSER New	—
MICHAEL WARD	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Bills named: H.R. 485 (118th), H.R. 2630 (118th), S. 652 (118th), S. 3702 (118th), H.R. 7165 (118th)

Medicare/Medicaid MMM

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -S. 3109 the Alleviating Barriers for Caregivers Act -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Medicare Advantage Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and D Payment Policies and Draft Calendar Year (CY) 2025 Part D Redesign Instructions

Lobbyist	Covered position, as disclosed
ADINA ROSE LASSER	—
MICHAEL WARD	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 3109 (118th)

Budget/Appropriations BUD

-FY24 report language for the Food and Drug Administration -FY25 report language for the Food and Drug Administration -FY25 report language for the Medicare Program -National Institute of Allergy and Infectious Diseases

Lobbyist	Covered position, as disclosed
ADINA ROSE LASSER	—
MICHAEL WARD	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.